Miscellaneous genitourinary tract agents
https://themeditary.com/breastfeeding/phenazopyridine-use-while-breastfeeding-11678.html

Phenazopyridine use while Breastfeeding

Drug Detail:Uristat ultra (Phenazopyridine [ fen-ay-zoe-pir-i-deen ])

Drug Class: Miscellaneous genitourinary tract agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Phenazopyridine Levels and Effects while Breastfeeding

Summary of Use during Lactation

The safety of phenazopyridine is not established in infants or during breastfeeding. Because it can cause methemoglobinemia, sulfhemoglobinemia, and hemolytic anemia, it should be avoided while breastfeeding, especially with an infant under 1 month of age or with glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Phenazopyridine

CAS Registry Number

94-78-0

Drug Class

  • Breast Feeding
  • Lactation
  • Anesthetics, Urinary

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Share this Article
Latest News
Related Drugs